Cytheris
Advancing therapies to rejuvenate and strengthen the immune systems of patients facing cancer, chronic infections, and intensive treatments.
General Information
Get notified when Cytheris moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Cytheris
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
About Cytheris
Taxonomy: biopharmaceutical company, clinical-stage, immune modulation, immune system, cancer treatment, chronic infections, HIV, HCV, HBV, lympho-depleting treatments, chemotherapy, radiotherapy, bone marrow transplantation, hematopoietic cell transplantation, drug development
Funding Rounds & Investors (3)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series D | •••••• | 5 |
|
07 Jun 2010 |
| Debt Financing | •••••• | 1 |
|
15 Jul 2008 |
| Series B | •••••• | 4 |
|
25 Oct 2006 |
Cytheris Alternatives & Competitors
Advancing safer, more precise therapies with unparalleled speed, driven by pioneering transplant res...
The Immune Tolerance Network (ITN) is a collaborative network for clinical research, funded by the N...
Adding Quality Years of Life
FAQ About Cytheris
Don't just browse. Track.
Signal Tracker monitors Cytheris and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.
